EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Amyloid precursor protein and presenilin‐1 knock‐in immunodeficient mice exhibit intraneuronal Aβ pathology, microgliosis, and extensive neuronal loss

Pravin Yeapuri, Jatin Machhi, Emma G Foster, Rana Kadry, Shaurav Bhattarai, Yaman Lu, Susmita Sil, Roshan Sapkota, Shefali Srivastava, Mohit Kumar, Tsuneya Ikezu, Larisa Y Poluektova und 2 weitere

Alzheimer's & Dementia · 2025

DOI: 10.1002/alz.70084 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2025. Verfasst von Pravin Yeapuri und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Experimental Neuroscience, Center for Neurodegenerative Disorders, College of Medicine, University of Nebraska Medical…. Hauptthemen laut MEDLINE: Amyloid beta-Protein Precursor, Presenilin-1, Alzheimer Disease, Neurons. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, NIH HHS, NIMH NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION Transgenic mice overexpressing familial Alzheimer's disease (AD) mutations (FAD) show non‐physiological traits, and their immunocompetent backgrounds limit their use in AD immunotherapy research. Preclinical models that reflect human immune responses in AD are needed. METHODS Using CRISPR‐Cas9, we developed single (NA) and double (NAPS) knock‐in (KI) amyloid precursor protein (APP) KM670,671NL (Swedish) and presenilin 1 (PS 1) M146V FAD mutations on an immunodeficient NOG (NOD.Cg‐Prkdc scid Il2rg tm1Sug /JicTac) background. The models were confirmed by Sanger sequencing and evaluated for AD‐like pathology. RESULTS Both NA and NAPS mice developed pathology without overexpression artifacts. Mutation‐induced upregulation of APP‐CTF‐β led to intraneuronal human amyloid beta (Aβ) (6E10) deposits and amyloid‐associated microgliosis as early as 3 months, which increased with age. The addition of the PS 1 M146V mutation doubled the amyloid load. The models displayed broad neuronal loss, resulting in brain atrophy in older mice. DISCUSSION These models replicate intraneuronal amyloid pathology and, with human immune reconstitution potential, enable novel studies of human immune responses in AD. Highlights A novel Alzheimer's disease (AD) knock‐in (KI) mouse was developed and characterized on an immunodeficient NOG background. The model provides a platform for human immune studies and the evaluation of immunotherapies for AD. The KI mice demonstrate intraneuronal Aβ deposits and amyloid‐associated microglial reactions. KI mice demonstrate extensive neuronal loss. Human immune reconstitution enables studies of infectious AD co‐morbidities, such as the human immunodeficiency and herpes simplex viruses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amyloid beta-Protein PrecursorPresenilin-1Alzheimer DiseaseNeuronsGliosisAmyloid beta-PeptidesAnimalsMice, TransgenicMiceDisease Models, AnimalGene Knock-In TechniquesHumansBrainMutationMicroglia

Stichwörter der Autor:innen

APPAlzheimer's diseasePS1human immune reconstitutionimmunodeficient NOG backgroundintraneuronal Aβ depositionknock‐in micemicrogliosisneuronal losstranslational AD research models

Substanzen

Amyloid beta-Protein PrecursorPresenilin-1Amyloid beta-Peptides

Autor:innen und Institutionen

  • Department of Pharmacology and Experimental Neuroscience, Center for Neurodegenerative Disorders, College of Medicine, University of Nebraska Medical Center, Omaha, Nebraska, USA.
  • Department of Neuroscience, Mayo Clinic Florida, Jacksonville, Florida, USA.

Förderung

  • NINDS NIH HHS
  • NIH HHS
  • NIMH NIH HHS
  • NIGMS NIH HHS
  • Frances and Louie Blumkin and Harriet Singer Research Foundations
  • NIA NIH HHS
  • Carol Swarts, MD Emerging Neuroscience Research Laboratory
  • NIDA NIH HHS

Zitieren

APA

Yeapuri, P., Machhi, J., Foster, E. G., Kadry, R., Bhattarai, S., Lu, Y., Sil, S., Sapkota, R., Srivastava, S., Kumar, M., Ikezu, T., Poluektova, L. Y., Gendelman, H. E., & Mosley, R. L. (2025). Amyloid precursor protein and presenilin‐1 knock‐in immunodeficient mice exhibit intraneuronal Aβ pathology, microgliosis, and extensive neuronal loss. Alzheimer's & Dementia. https://doi.org/10.1002/alz.70084

Vancouver

Yeapuri P, Machhi J, Foster EG, Kadry R, Bhattarai S, Lu Y, et al. Amyloid precursor protein and presenilin‐1 knock‐in immunodeficient mice exhibit intraneuronal Aβ pathology, microgliosis, and extensive neuronal loss. Alzheimer's & Dementia. 2025. doi:10.1002/alz.70084

BibTeX
@article{Yeapuri2025,
  author = {Yeapuri, Pravin and Machhi, Jatin and Foster, Emma G and Kadry, Rana and Bhattarai, Shaurav and Lu, Yaman and Sil, Susmita and Sapkota, Roshan and Srivastava, Shefali and Kumar, Mohit and Ikezu, Tsuneya and Poluektova, Larisa Y and Gendelman, Howard E and Mosley, Rodney Lee},
  title = {Amyloid precursor protein and presenilin‐1 knock‐in immunodeficient mice exhibit intraneuronal Aβ pathology, microgliosis, and extensive neuronal loss},
  journal = {Alzheimer's & Dementia},
  year = {2025},
  doi = {10.1002/alz.70084}
}
Kostenlos starten →